Multiplex proteomic analysis of cells in fine needle aspiration samples: how soon can we expect to individualize therapy by comparing pre- and posttreatment biopsies?

Clin Chem. 2014 Sep;60(9):1143-5. doi: 10.1373/clinchem.2014.222828. Epub 2014 Apr 9.

Authors

Lance A Liotta¹, Emanuel F Petricoin 3rd²

Affiliations

¹ Center for Applied Proteomics and Molecular Medicine, George Mason University, Manassas, VA. lliotta@gmu.edu.
² Center for Applied Proteomics and Molecular Medicine, George Mason University, Manassas, VA.

PMID: 24718910
DOI: 10.1373/clinchem.2014.222828

No abstract available

Publication types

Research Support, Non-U.S. Gov't

MeSH terms

Biopsy, Fine-Needle*
Humans
Neoplasms / diagnosis
Neoplasms / therapy
Proteomics* / trends
Sensitivity and Specificity
Time Factors